Renal Hemodynamics and Renin-Angiotensin-Aldosterone System Profiles in Patients With Heart FailureYuliya Lytvyn, John D. Parker, Jaya Prakash N. Ambinathan et al.|Journal of Cardiac Failure|2021Cited by 9
1127-P: SGLT2 Inhibition (SGLT2i) Mediated Urinary Glucose Excretion (UGE) Associations with Metabolic and Renal Hemodynamic ParametersYuliya Lytvyn, Ele Ferrannini, ANDRIY LYTVYN et al.|Diabetes|2019Cited by 0
528-P: The Effect of Angiotensin II (ANG II) Infusion on Plasma Uric Acid (PUA) in Patients with Type 1 Diabetes (T1D)Yuliya Lytvyn, David Cherney, Julie A. Lovshin et al.|Diabetes|2019Cited by 0
527-P: Renal Hemodynamic and RAAS Profiles in Patients with Type 2 Diabetes (T2D) and Heart Failure (HF)Yuliya Lytvyn, John D. Parker, Lucas C. Godoy et al.|Diabetes|2019Cited by 0